Viewing Study NCT01226966


Ignite Creation Date: 2025-12-24 @ 4:25 PM
Ignite Modification Date: 2025-12-28 @ 2:00 PM
Study NCT ID: NCT01226966
Status: COMPLETED
Last Update Posted: 2017-02-13
First Post: 2010-10-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Observational Study on Efficacy and Safety of Liraglutide in Subjects With Type 2 Diabetes
Sponsor: Novo Nordisk A/S
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2010-09
Start Date Type: None
Primary Completion Date: 2013-11
Primary Completion Date Type: ACTUAL
Completion Date: 2013-11
Completion Date Type: ACTUAL
First Submit Date: 2010-10-20
First Submit QC Date: None
Study First Post Date: 2010-10-22
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2017-02-10
Last Update Post Date: 2017-02-13
Last Update Post Date Type: ACTUAL